These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29087304)

  • 41. Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles.
    Gorny MK; Stamatatos L; Volsky B; Revesz K; Williams C; Wang XH; Cohen S; Staudinger R; Zolla-Pazner S
    J Virol; 2005 Apr; 79(8):5232-7. PubMed ID: 15795308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded and -unliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virions.
    Rathinakumar R; Dutta M; Zhu P; Johnson WE; Roux KH
    J Virol; 2012 Feb; 86(3):1820-31. PubMed ID: 22090143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
    Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex.
    Park EJ; Gorny MK; Zolla-Pazner S; Quinnan GV
    J Virol; 2000 May; 74(9):4183-91. PubMed ID: 10756031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes.
    Martin L; Stricher F; Missé D; Sironi F; Pugnière M; Barthe P; Prado-Gotor R; Freulon I; Magne X; Roumestand C; Ménez A; Lusso P; Veas F; Vita C
    Nat Biotechnol; 2003 Jan; 21(1):71-6. PubMed ID: 12483221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity.
    Diskin R; Marcovecchio PM; Bjorkman PJ
    Nat Struct Mol Biol; 2010 May; 17(5):608-13. PubMed ID: 20357769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.
    McKenna PM; Pomerantz RJ; Dietzschold B; McGettigan JP; Schnell MJ
    J Virol; 2003 Dec; 77(23):12782-94. PubMed ID: 14610200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fusion proteins of HIV-1 envelope glycoprotein gp120 with CD4-induced antibodies showed enhanced binding to CD4 and CD4 binding site antibodies.
    Chen W; Feng Y; Wang Y; Zhu Z; Dimitrov DS
    Biochem Biophys Res Commun; 2012 Sep; 425(4):931-7. PubMed ID: 22906742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
    Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
    J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity.
    Xiao X; Phogat S; Shu Y; Phogat A; Chow YH; Wei OL; Goldstein H; Broder CC; Dimitrov DS
    Vaccine; 2003 Oct; 21(27-30):4275-84. PubMed ID: 14505910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allosteric induction of the CD4-bound conformation of HIV-1 Gp120.
    Roitburd-Berman A; Dela G; Kaplan G; Lewis GK; Gershoni JM
    Retrovirology; 2013 Dec; 10():147. PubMed ID: 24304511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4-induced epitopes in the HIV envelope glycoprotein, gp120.
    DeVico AL
    Curr HIV Res; 2007 Nov; 5(6):561-71. PubMed ID: 18045112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.
    Lai RP; Yan J; Heeney J; McClure MO; Göttlinger H; Luban J; Pizzato M
    PLoS Pathog; 2011 Dec; 7(12):e1002442. PubMed ID: 22194689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.
    Kant S; Zhang N; Barbé A; Routy JP; Tremblay C; Thomas R; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Harris M; Dupuy FP; Bernard NF
    Front Immunol; 2020; 11():583820. PubMed ID: 33101312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions.
    Cavacini LA; Duval M; Robinson J; Posner MR
    AIDS; 2002 Dec; 16(18):2409-17. PubMed ID: 12461414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV: conformational camouflage.
    Jardetzky T
    Nature; 2002 Dec; 420(6916):623-4. PubMed ID: 12478278
    [No Abstract]   [Full Text] [Related]  

  • 58. CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies.
    Madani N; Princiotto AM; Schön A; LaLonde J; Feng Y; Freire E; Park J; Courter JR; Jones DM; Robinson J; Liao HX; Moody MA; Permar S; Haynes B; Smith AB; Wyatt R; Sodroski J
    J Virol; 2014 Jun; 88(12):6542-55. PubMed ID: 24696475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding.
    Guan Y; Pazgier M; Sajadi MM; Kamin-Lewis R; Al-Darmarki S; Flinko R; Lovo E; Wu X; Robinson JE; Seaman MS; Fouts TR; Gallo RC; DeVico AL; Lewis GK
    Proc Natl Acad Sci U S A; 2013 Jan; 110(1):E69-78. PubMed ID: 23237851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection.
    Liu P; Overman RG; Yates NL; Alam SM; Vandergrift N; Chen Y; Graw F; Freel SA; Kappes JC; Ochsenbauer C; Montefiori DC; Gao F; Perelson AS; Cohen MS; Haynes BF; Tomaras GD
    J Virol; 2011 Nov; 85(21):11196-207. PubMed ID: 21865397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.